David Mussafer, chairman of Advent International

Ad­vent to sell stake in man­u­fac­tur­er and drug de­vel­op­er in a deal worth over $1B — re­port

Af­ter al­most three years of in­vest­ment, pri­vate eq­ui­ty firm Ad­vent In­ter­na­tion­al may look to sell its part in Bio­duro-Sun­dia.

A Reuters

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.